Skip to content

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07281287
Enrollment
40
Registered
2025-12-15
Start date
2025-02-01
Completion date
2030-12-31
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Counseling, Financial Toxicity, Oncology

Keywords

Financial Navigation, Out of pocket cost, Oncology, oncology Financial hardship

Brief summary

The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are: 1. How did oncology financial navigation implementation strategies affect implementation outcomes? 2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress? 3. How were implementation strategies utilized to overcome barriers to oncology financial navigation? Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.

Detailed description

Guided by the RE-AIM Extension for Equitable Sustainability framework, the investigators will use a series of implementation and effectiveness aims to evaluate equitable implementation of oncology financial navigation into routine cancer care delivery. The investigators hypothesize the proposed assessment will identify potential areas to improve implementation of oncology financial navigation, which will result in better financial and clinical outcomes for patients with cancer. The investigators propose a pragmatic, hybrid effectiveness-implementation study to assess outcomes of oncology financial navigation delivered as routine cancer care and collect information on strategies to address implementation barriers. Outcomes will be assessed overall and for inequities by race, residence, and insurance status using the following specific aims: Aim 1. Track oncology financial navigation implementation strategies and their effect on implementation outcomes Aim 2. Evaluate oncology financial navigation effectiveness Aim 3. Assess how implementation strategies were utilized to overcome barriers to oncology financial navigation

Interventions

Oncology financial navigation is an evidence-based intervention which helps patients prepare for out-of-pocket treatment costs, optimize health insurance, and access financial resources to reduce cancer-related financial hardship.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This will be a secondary data analysis of patient-reported data routinely collected since 2020 for patients with cancer seen at the UAB Medical Oncology clinic. All patients with data will be included in the analysis, as this is an evaluation of oncology financial navigation integration into real-world clinical teams. Therefore, due to a lack of comparable controls during the oncology financial navigation intervention, we will use historical controls matched by sociodemographic and cancer characteristics for comparison.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aim 1: Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for: 1. All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic 2. UAB oncology financial navigators

Exclusion criteria

None. Aim 2: Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include: 1. Patients with cancer seen at the UAB Medical Oncology clinic 2. Patients with non-missing patient-reported outcome data

Design outcomes

Primary

MeasureTime frameDescription
Change in financial hardship6 months post-initiation of systemic therapyChange in patient-reported financial distress (COmprehensive Score for financial Toxicity)
Change in financial difficulties6 months post-initiation of systemic therapyChange in patient-reported financial difficulties (trouble paying for basic needs, utilities, transportation or lodging for treatment, medications, medical supplies, upfront medical payments, insurance or medical bills, child or eldercare, and employment or disability issues)
Change in quality of life6 months post-initiation of systemic therapyChange in patient-reported quality of life (PROMIS v1.1 Global Health)
Change in psychological distress6 months post-initiation of systemic therapyChange in patient-reported psychological distress (National Comprehensive Cancer Network Distress Thermometer)
Utilization of implementation strategiesQuarterly tracking of strategies with monthly assessment of implementation outcomes, through study completion, an average of 4 yearsTrack oncology financial navigation implementation strategies using the Expert Recommendations for Implementing Change (ERIC) implementation strategy taxonomy and their effect on implementation outcomes of Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM)
Patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategiesAnnually through study completion, an average of 4 yearsUsing qualitative interviews, we will assess patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies

Countries

United States

Contacts

CONTACTHayden Reeves, BS
haydenreeves@uabmc.edu205-996-4109
CONTACTCourtney Williams, DrPH
courtneywilliams@uabmc.edu205-975-0462
PRINCIPAL_INVESTIGATORCourtney Williams, DrPH

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026